Beyond Sequence: Building the Next Generation of Structural Genomics Platforms
Contributed Commentary by Claude E. Gagna, Ph.D., Professor, Department of Biological and Chemical Sciences, New York Institute of Technology
July 31, 2026 | For more than three decades, genomics has been driven by a simple but extraordinarily successful premise: biological information is encoded in nucleotide sequence. Advances in sequencing technologies, genome assembly, annotation, variant analysis, and computational biology have transformed our understanding of genes and genomes. Yet in my view, an important reality is becoming increasingly difficult to ignore. DNA and RNA are not merely repositories of sequence information. They are dynamic molecules capable of adopting alternative and multistranded conformations that influence gene regulation, genome stability, cellular function, and disease.
The scientific significance of these unusual, noncanonical nucleic acid structures is no longer in question. Research has linked G-quadruplexes, i-motifs, left-handed Z-DNA, triplex structures, RNA G-quadruplexes, R-loops, and structured RNA conformations to transcriptional regulation, chromatin organization, DNA repair, replication dynamics, and genomic instability. These structures are increasingly recognized as contributors to both normal cellular function and human disease.
Despite these advances, structural genomics remains largely inaccessible to many researchers. The problem is not a lack of prediction algorithms. The field has produced an impressive collection of computational prediction tools capable of identifying potential noncanonical DNA and RNA conformations across genes and genomes. The challenge is that these tools often operate independently, use different scoring systems, require specialized computational expertise, and produce outputs that are difficult to compare or interpret.
I have encountered this problem directly while developing structure-aware genomic analysis workflows. Individual tools can often answer narrow questions very well, but the larger biological question usually requires integration. A researcher may not simply want to know whether a predicted structure exists. The more useful question is where it occurs within a gene, how it relates to regulatory elements or mutations, and whether it varies between normal and altered sequences.
This situation resembles the early years of genomics itself. Before the emergence of integrated genome browsers, standardized databases, and user-friendly analytical platforms, genomic data were often fragmented across specialized resources. The eventual success of genomics depended not only on scientific discovery but also on practical software ecosystems that made complex data accessible to a broad scientific community. I believe structural genomics now stand at a similar crossroads.
The practical implications are becoming increasingly apparent in disease-focused research. Consider a cancer investigator studying BRCA1 or BRCA2. Conventional canonical-based genomic analysis identifies mutations, regulatory elements, and expression patterns. A structure-aware approach could additionally reveal regions predicted to form G-quadruplexes, Z-DNA, triplex DNA, or R-loops that may influence genomic stability and gene regulation, providing a more comprehensive view of disease-associated genes. The next major advance may not come from creating yet another prediction algorithm. Instead, it may come from integrated structural genomics platforms that bring together prediction, visualization, annotation, comparison, and interpretation within a unified environment.
Researchers increasingly need the ability to analyze genes through multiple dimensions simultaneously. A modern genomics workflow should not simply identify coding regions, regulatory elements, variants, and expression patterns. It should also provide information about structural propensity. Investigators should be able to visualize where predicted G-quadruplexes, Z-DNA regions, triplex-forming sequences, R-loops, and structured RNA elements occur relative to promoters, enhancers, splice junctions, mutation hotspots, and disease-associated variants.
Equally important is the continued development of methods that improve our understanding of how diverse structural features may contribute to gene function and regulation. Biological systems rarely operate through a single regulatory mechanism. A genomic region may contain overlapping sequence signals, epigenetic modifications, protein-binding sites, and structural features that collectively influence gene behavior. Future structural genomics platforms must therefore function as integrative environments rather than isolated prediction tools.
Artificial intelligence will likely play an important role in this transition. Machine learning models are becoming increasingly capable of recognizing complex regulatory patterns across large genomic datasets. Foundation models trained on genomic information may eventually incorporate structural features alongside sequence-based signals, enabling more comprehensive predictions of gene function, regulatory activity, and disease susceptibility. The emergence of genomic foundation models further highlights this opportunity. Future genomic AI systems may incorporate structural propensity alongside sequence, epigenetic, transcriptional, and regulatory data. Structural genomics, therefore, represents a potentially important source of biological context for predictive modeling and genomic interpretation.
However, the successful implementation of artificial intelligence requires more than predictive power. Researchers need user-friendly prediction tools, transparency, interpretability, and confidence in the results. Black-box predictions are unlikely to gain widespread acceptance unless users can understand how predictions are generated and how they relate to established biological knowledge. Future platforms must therefore balance automation with interpretability.
Visualization represents another critical frontier. Structural genomics is inherently spatial. Scientists need intuitive methods for exploring structural features within genes and across genomic landscapes. Interactive visualization tools that combine sequence, annotation, structural predictions, and experimental data could improve research productivity and scientific understanding. The implications extend beyond basic research. Structural genomics may influence translational medicine, drug discovery, biotechnology, and genomic risk assessment. Noncanonical nucleic acid structures are increasingly being investigated as therapeutic targets, biomarkers, and determinants of genomic instability. As these applications mature, researchers will require platforms capable of translating structural information into actionable biological insights.
Education represents another important opportunity. Most students learn about DNA primarily as a right-handed double helix (i.e., B-DNA) and about RNA as a messenger molecule. Future educational tools could help students visualize the incredibly dynamic structural behavior of nucleic acids and encourage them to think about genomes not only as sequences but also as structural systems.
The future of genomics will almost certainly involve greater integration of sequence, structure, function, and disease. Advances in artificial intelligence, cloud computing, genomic visualization, and large-scale data integration are creating opportunities to transform structural genomics from a specialized discipline into a routine component of biological research. The scientific foundation has already been established. The biological relevance of noncanonical nucleic acid structures is increasingly supported by experimental and computational evidence. What remains is the development of robust, user-centered computational ecosystems that bring structural information into everyday genomic analysis.
The next decade of genomics may be defined not only by what genomes encode, but also by how their structural potential is interpreted and applied. A deeper understanding of the relationships among sequence, structure, regulation, and genome organization may ultimately provide a more complete picture of genome biology. As the field moves beyond sequence alone, structural genomics are poised to become an important component of biological discovery, aging research, translational medicine, biotechnology, and precision genomics.
Claude E. Gagna, Ph.D., is a professor of biological sciences at the New York Institute of Technology. For more than three decades, his research has focused on molecular biology, genomics, and noncanonical DNA and RNA structures. His work explores how nucleic acid conformation influences gene regulation, genome stability, and disease. He can be reached at [email protected] or [email protected].


